Andrew Draganski
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.3MFederal grants as PI4 awards
0Patents grantedNone matched
28Papers151 citations
Federal awards and patents by year
AwardsPatents
4 awards · $2.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 1, 2023 | NIH | STTR Phase I Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus. | $148K | Zylo Therapeutics Inc. with PHILADELPHIA RESEARCH AND EDU FOUNDATION |
| Sep 15, 2022 | NIH | STTR Phase I Optimization of a nanoparticle-based topical PDE5i formulation for treatment of erectile dysfunction | $263K | Zylo Therapeutics Inc. with ALBERT EINSTEIN COLLEGE OF MEDICINE, INC |
| Jul 19, 2021 | NIH | SBIR Phase II Development of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors | $1.7M | Zylo Therapeutics Inc. |
| Sep 13, 2019 | NIH | STTR Phase I Optimization of microparticle-based topical treatments for treating erectile dysfunction in patients refractory to oral PDE5 inhibitors | $225K | Zylo Therapeutics Inc. with ALBERT EINSTEIN COLLEGE OF MEDICINE, INC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#835
Awards as PI#566
Patents#273
Companies
- Zylo Therapeutics Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.